Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review (Q35126308)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

30 June 2019

1 reference

PubMed publication ID

systematic review

1 reference

PubMed publication ID

Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

chronic progressive multiple sclerosis

1 reference

30 June 2019

1

object named as

Jan-Patrick Stellmann

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christoph Heesen

5

object named as

Christoph Heesen

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Anneke Neuhaus

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Christian Lederer

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Martin Daumer

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

20 March 2014

3 references

Europe PubMed Central

PubMed publication ID

6 August 2017

25 April 2019

30 June 2019

3 references

Europe PubMed Central

PubMed publication ID

6 August 2017

25 April 2019

30 June 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

e92761

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution 4.0 International

2 references

Europe PubMed Central

25 April 2019

Europe PubMed Central

30 June 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Clinical scales in progressive MS: predicting long-term disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Natural history of primary progressive multiple sclerosis

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092761

21 January 2018

Primary and secondary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

13 July 2018

Cortical lesion load associates with progression of disability in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Lesion enhancement diminishes with time in primary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

The natural history of primary progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Disability as an outcome in MS clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

The natural history of primary progressive MS in British Columbia, Canada.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3961431

27 September 2018

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092761

21 January 2018

The natural history of multiple sclerosis: a geographically based study 9: Observations on the progressive phase of the disease

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092761

21 January 2018

Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092761

21 January 2018

Surrogate endpoints for EDSS worsening in multiple sclerosis: A meta-analytic approach: Measuring disability in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0092761

21 January 2018

Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapses and progression of disability in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24651401

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0092761

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2014PLoSO...992761S

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35126308&oldid=2190163013"